About the book
Thyroid cancer is the most common endocrine cancer. The incidence of thyroid cancer is increasing worldwide. New developments have emerged in the research efforts to define the molecular biology and pathophysiology of thyroid cancer. Various oncogenes which are implicated in thyroid cancer pathogenesis have been described and their significance in thyroid cancer prognosis has been investigated. The prognosis of specific thyroid cancer subtypes has been investigated. The therapeutic and prognostic significance of lymph node metastatic disease has been defined. Thyroid cancer treatment is now in the focus of research interest. The use of surgery and its extent in the treatment of thyroid cancer is discussed. The role of radioiodine in the treatment of thyroid cancer is also intensively discussed. Major advances in the drug treatment of advanced thyroid cancer have emerged. In particular, the use of multiple kinase inhibitors has revolutionized the management of advanced thyroid cancer. The treatment of medullary thyroid carcinoma is also a field which has seen major advances. Various efforts have been made to delineate the biology and pathophysiology of anaplastic thyroid carcinoma, which is a deadly cancer, and some have shed some light into its pathogenesis.